Eikon Therapeutics Files for IPO Led By Merck Veterans

Eikon Therapeutics Inc. filed for an initial public offering to help fund its advanced pipeline of cancer drugs.

By Anthony Hughes · Bloomberg Markets

Eikon Therapeutics Inc. filed for an initial public offering to help fund its advanced pipeline of cancer drugs.